Zacks Investment Research on MSN
Wall Street analysts think Assertio (ASRT) could surge 249.87%: Read this before placing a bet
Assertio (ASRT) closed the last trading session at $11.13, gaining 4.3% over the past four weeks, but there could be plenty ...
$ASRT insiders have traded $ASRT stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales. Here’s a ...
Assertio Holdings has dropped substantially and is down more than 70% in the past year. Assertio Holdings appears to have been oversold based on quantitative factors. It trades at a very low ...
Shares of Assertio (NASDAQ:ASRT) closed 8% higher Monday after the company refuted allegations leveled by activist investor Buxton Helmsley over its accounting practices and approval of its drug ...
Zacks Investment Research on MSN
Is Assertio (ASRT) stock outpacing its medical peers this year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Assertio (ASRT) is a stock that can certainly grab the attention ...
Wall Street Zen cut shares of Assertio (NASDAQ:ASRT – Free Report) from a hold rating to a sell rating in a research report released on Thursday. Other equities research analysts have also recently ...
Assertio Therapeutics (ASRT) has shared an announcement. At a recent Annual Meeting, stockholders approved significant changes to the Company’s incentive plan and bylaws, including a 3.39 million ...
Assertio Therapeutics ( (ASRT)) just unveiled an announcement. On December 19, 2025, Assertio Holdings, Inc. filed an amendment to its certificate of incorporation to implement a 1-for-15 reverse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results